The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. Different types of research studies provide us with different types of information. What makes a good research study, anyway?

Research and Development 121

Research and Development Data THC Clinical Trials 121

Cannabis Law Report

AUGUST 19, 2019

The Therapeutic Goods Administration (TGA), Australia’s medicines regulatory body (akin to the FDA in the USA and EMA in Europe), is currently collecting some potentially useful information from doctors prescribing medicinal cannabis around the progress of their patients. Read full article: [link].

Medicine 45

Medicine Patients Clinical Trials Access 45

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

Healer

DECEMBER 17, 2021

The safety profile of CBD has been acknowledged by major health agencies, such as the World Health Organization (WHO), showing that it’s well-tolerated by animals and humans and rarely produces any dangerous side effects. Numerous studies have shown that CBD is a safe, non-impairing, and non-habit-forming substance.

CBD 98

CBD THC Conditions Medicine 98

Cannabis Law Report

JUNE 10, 2021

The Traffic Safety Culture Index is an annual survey with national scope and multiple measures relevant to driving after marijuana use. Because THC presence is an imperfect proxy for impairment [ 10 ], driving data may be limited in clarifying what traffic safety risks, if any, are associated with permissive marijuana policies.

Policy 45

Policy Safety Marijuana Data 45

MMJ Recs

JULY 11, 2024

In this article, we explore the role of medical marijuana in addressing insomnia, examining its effectiveness, safety considerations, legal aspects, and practical considerations for patients and healthcare providers. Medical marijuana is a potential treatment for insomnia, and it offers an alternative to traditional pharmaceuticals.

Sleep 111

Sleep Treatment Research and Development Therapy 111

Cannabis Law Report

JULY 9, 2021

This article provides an overview of the current state of legality of common psychedelic substances, and some of the potential therapeutic uses to which psychedelics may be applied. See Usona Institute, A Study of Psilocybin for Major Depressive Disorder (MDD) , Clinical Trial ID NCT03866174, available at [link].

Law 81

Law Therapy Clinical Trials Research and Development 81

MMJ Recs

NOVEMBER 30, 2023

In this comprehensive article, we’ll delve into the potential benefits and challenges of using MMJ as a treatment for epilepsy, as well as share the perspectives of both medical professionals and patients who have experienced the promising effects of MMJ on seizure control and overall well-being.

Epilepsy 105

Epilepsy Treatment Patients Strains 105

MMJ Recs

JULY 3, 2024

From the pressures of work and personal relationships to the constant bombardment of information on social media and the news, many individuals find themselves struggling to cope with these challenges. In this article, we’ll explore how CBD benefits anxiety relief. Image by Suzy Hazelwood on Pexels.

CBD 52

CBD Research and Development Clinical Trials THC 52

MMJ Recs

JULY 5, 2024

In this article, we explore the scientific understanding of THC, exploring its chemical structure, mechanisms of action within the human body, potential health benefits, associated risks, and legal implications. These trials aim to provide more conclusive evidence for its use in mainstream medicine.

THC 52

THC Research and Development Chronic Pain Cannabinoids 52

Cannabis Law Report

JUNE 11, 2019

Article by Jorge P. This article will examine how courts have responded to claims for cannabis, as an element of future care costs, in personal injury cases. Joinson had obtained an exemption from Health Canada for medical marijuana but, according to the court, it had been obtained based on incorrect information. June 6 2019.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45

MMJ Recs

JULY 19, 2024

In this article, we take a further look into the science behind cannabis and anxiety, examining different strains and their suitability for managing anxiety symptoms. By understanding the mechanisms and nuances of cannabis use, individuals can make informed decisions about integrating it into their treatment regimen.

Strains 52

Strains Indica Clinical Trials Treatment 52

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. A total of 117 articles were retrieved for analysis, the majority of which were news stories for a physician audience.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

DECEMBER 7, 2021

Radicle Science re-imagined clinical trials resulting in 10x cheaper, faster, and larger studies that can finally prove or predict which nonprescription health products to use for a desired effect, benefiting consumers, healthcare providers and brands.”.

Clinical Trials 40

Clinical Trials CBD Data Sleep 40

Cannabis Law Report

NOVEMBER 26, 2021

With the anticipated launch of Pfizer’s oral COVID-19 antiviral drug candidate, Can-Fite has made a strategic decision to end its COVID-19 program and to focus its resources on its other clinical programs, all in advanced clinical trials. For more information please visit: www.can-fite.com. Financial Results.

Clinical Trials 40

Clinical Trials Research and Development Treatment Data 40

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. But the main issue with hemp derived products and their safety is less about the CBD and more about everything else in them. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

MAY 13, 2019

Medical professionals want more information about medicinal cannabis before they start prescribing it to patients, a new study has found. Data Availability: All relevant data are within the paper and its Supporting Information files. Funding: The author(s) received no specific funding for this work.

Medicine 45

Medicine Research and Development Clinical Trials Data 45

Healer

DECEMBER 17, 2021

The safety profile of CBD has been acknowledged by major health agencies, such as the World Health Organization (WHO), showing that it’s well-tolerated by animals and humans and rarely produces any dangerous side effects. Numerous studies have shown that CBD is a safe, non-impairing, and non-habit-forming substance.

CBD 52

CBD THC Conditions Medicine 52

Cannabis Law Report

OCTOBER 29, 2019

ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement. Wakshlag, DVM, Ph.D.,

Safety 45

Safety CBD Clinical Trials Oil 45

The Cannigma

MARCH 12, 2021

MSO: So much of that has to do with the lack of education among medical professionals, but also the lack of scientific information, saying which cannabis products are good for what symptoms or what conditions and hopefully, we get there one day. And in my belief, it should be cannabis, because of the safety profile, number one.

Legalization 132

Legalization Patients Education Dispensary 132

The Cannigma

APRIL 8, 2021

Listen & Subscribe: As both a regulated medicine and something people use for wellness and even recreation, the information gaps that exist for cannabis users are unprecedented. Any other medication and you’re lawfully entitled to speak to a pharmacist,” explains Dr. Codi Peterson, a clinical pharmacist and medical cannabis professional.

Medicine 122

Medicine Cannabinoids Cannabis THC 122

The Cannigma

JANUARY 13, 2023

This article includes strain names as a starting point for you to find flower or products near you that match the chemical makeup, not the exact strain name. Russo concluded the evidence he examined “supports experimental protocols of cannabis usage in migraine treatment should go forward employing modern controlled clinical trials.”

Terpenes 139

Terpenes Strains THC Treatment 139

Cannabis Law Report

JULY 24, 2019

FDA approves a new drug on the basis of scientific data and information demonstrating that the drug is safe and effective. Information on your website and social media accounts suggests that you may intend to market your CBD products as dietary supplements. 331(d) and 355(a). Dietary Supplement Labeling. 321(ff)(3)(B)(i) and (ii).

CBD 51

CBD Tincture Pets Chronic Pain 51

Cannabis Law Report

FEBRUARY 28, 2022

Clinical trials are producing promising results, creating enthusiasm for commercializing and patenting psychedelics. 1025, 1026 (2021) (reporting significant improvement of PTSD symptoms following treatment with MDMA in clinical trial); see also Alec J. See General Information Concerning Patents , U.S.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. She is author, co-author, and co-editor of twenty-two books, two special-edition journals, and several peer-reviewed articles.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

OCTOBER 17, 2019

Many of these are meant to address public safety risks, especially for young people. We’re acknowledging that making cannabis illegal didn’t work, and that a more effective way to protect the health and safety of Canadians is to provide adults with access to a regulated and safe cannabis supply for non-medical purposes.”.

Law 40

Law Seed-To-Sale Hemp Recreational 40